申请人:Seino Ken-ichiro
公开号:US20090214596A1
公开(公告)日:2009-08-27
The present invention provides a nasal vaccine capable of intranasally inducing an effective immunity reaction. Specifically, the invention provides a nasal vaccine containing a compound having an NKT cell-activating action, particularly a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a compound represented by the formula (II):
wherein each symbol is as defined in the specification, and an immunogen in an amount effective for stimulating an immune response.